Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma Limited has submitted copies of its financial results for the quarter and year ended March 31, 2026, published on May 6, 2026 in the Mumbai editions of Business Standard (English) and Navakal (Marathi). This filing complies with SEBI Regulation 47, which mandates listed companies to publish their quarterly and annual financial results in newspapers. The full financial numbers were separately filed with the stock exchanges under Regulation 52. Note: This filing package also contains unrelated content from Tata Capital Limited, Magma General Insurance Limited, United Spirits Limited, and a municipal tender notice, which appear to be part of the scanned newspaper page rather than Ajanta Pharma's filings.
Routine regulatory compliance — publishing results in newspapers increases retail investor awareness. The actual financial performance figures and any market reaction would depend on the full results filed directly with the exchanges.